HARRY W JR ALCORN
CIK 1186761 · SVP, Clinical Operations · last filed 2021-09-15
HARRY W JR ALCORN is a SVP, Clinical Operations who has filed 8 SEC Form 4 insider transactions across 1 company since 2018. The most recent filing shows the insider bought $57.0K of DMAC on Sep 15, 2021. Across all open-market trades the lifetime net is +$145.0K, making them a net buyer over the disclosed history. Current disclosed insider exposure totals $248.5K across reported positions.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
$248.5K
1
8
$145.0K
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| DMAC | SVP, Clinical Operations | 43,981 | $5.65 | $248.5K | $145.0K | 8 | 2021-09-15 |
Recent Filings
8 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2021-09-15 | DMAC | Buy (P) | +15,000 | $57.0K | EDGAR |
| 2021-08-16 | DMAC | Buy (P) | +20,721 | $64.1K | EDGAR |
| 2021-07-29 | DMAC | Grant (A) | — | $0 | EDGAR |
| 2020-06-02 | DMAC | Grant (A) | — | $0 | EDGAR |
| 2019-08-16 | DMAC | Buy (P) | +7,260 | $19.4K | EDGAR |
| 2019-06-26 | DMAC | Grant (A) | — | $0 | EDGAR |
| 2019-03-29 | DMAC | Mixed | — | $668 | EDGAR |
| 2018-12-11 | DMAC | Buy (P) | +1,000 | $4.0K | EDGAR |